Skip to main navigation
Investors
Alnylam
John M. Maraganore Ph.D.
Recent Press Releases
View all releases
Jun 03,2026
Summary Toggle
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
May 19,2026
Summary Toggle
Alnylam Issues 2025 Corporate Responsibility Report
May 12,2026
Summary Toggle
New Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutrisiran as a First-Line Treatment Option Across ATTR-CM Patient Populations, Including Patients with a High Disease Burden
View all releases
: (Common):
Price:
Change (%):
Volume:
Data as of
Copyright Refinitiv. Minimum 15 minutes delay
Learn More
